Breast cancer can be categorized as (i) ERBB2/HER2 negative/hormone receptor-positive (~70% of all cases), (ii) ERBB2 positive (15–20% incidence), and (iii) triple-negative breast cancer (which lacks all three receptors, ERBB2, estrogen receptor and progesterone receptor). Here, ERBB2 is linked to breast carcinoma.